Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (91-100 of 265) with videos related to

Pageof 27
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2003
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational studyAlessandra Fabi, Mario Barduagni, Salvatore Lauro, et al.
The Breast Journal|November 6, 2009
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancerGiulio Metro, Diana Giannarelli, Donatello Gemma, et al.
Cancers|May 14, 2022
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future PerspectivesPaola Fuso, Margherita Muratore, Tatiana D'Angelo, et al.
Future Oncology (London, England)|June 6, 2020
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Malaguti, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Journal of Neuro-Oncology|March 31, 2010
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II studyAlessandra Fabi, Giulio Metro, Antonello Vidiri, et al.
Oncology|April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapiesAlessandra Fabi, G Metro, A Di Benedetto, et al.
Drug Design, Development and Therapy|December 8, 2015
Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsAlessandra Fabi, Diana Giannarelli, Paola Malaguti, et al.
Breast Cancer Research : BCR|April 13, 2017
Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry studyIole Cordone, Serena Masi, Valentina Summa, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|April 27, 2016
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and VomitingPaolo Bossi, Diego Cortinovis, Maria Cossu Rocca, et al.
Pageof 27

Showing results (91-100 of 265) with videos related to

Sort By:
Pageof 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2003
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational studyAlessandra Fabi, Mario Barduagni, Salvatore Lauro, et al.
The Breast Journal|November 6, 2009
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancerGiulio Metro, Diana Giannarelli, Donatello Gemma, et al.
Cancers|May 14, 2022
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future PerspectivesPaola Fuso, Margherita Muratore, Tatiana D'Angelo, et al.
Future Oncology (London, England)|June 6, 2020
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Malaguti, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Journal of Neuro-Oncology|March 31, 2010
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II studyAlessandra Fabi, Giulio Metro, Antonello Vidiri, et al.
Oncology|April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapiesAlessandra Fabi, G Metro, A Di Benedetto, et al.
Drug Design, Development and Therapy|December 8, 2015
Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsAlessandra Fabi, Diana Giannarelli, Paola Malaguti, et al.
Breast Cancer Research : BCR|April 13, 2017
Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry studyIole Cordone, Serena Masi, Valentina Summa, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|April 27, 2016
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and VomitingPaolo Bossi, Diego Cortinovis, Maria Cossu Rocca, et al.
Pageof 27